Adv Anat Pathol

1. BASAR M, Yol C, Chen JF, Al-Ahmadie H, et al
   Micropapillary Urothelial Carcinoma: A Review and Update.
   Adv Anat Pathol. 2026;33:e1-e8.
   

   >> Share

   
   

   
   Aktuelle Urol

2. NIEGISCH G, Zschabitz S, Klumper N, Eckstein M, et al
   [Current and future treatment stratification of metastatic urothelial carcinoma: a great opportunity for true precision oncology].
   Aktuelle Urol. 2026;57:46-51.
   

   >> Share

   
   
3. LANGE F, Gaisa NT, Bolenz C, Klumper N, et al
   [Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making].
   Aktuelle Urol. 2026;57:52-59.
   

   >> Share

   
   

   
   Ann Surg Oncol

4. LIU Q, Lu X, He C, Chen J, et al
   Correction: A Novel Model for Muscle-Invasive Bladder Cancer Diagnosis Using Contrast-Enhanced Ultrasound.
   Ann Surg Oncol. 2026 Feb 16. doi: 10.1245/s10434-026-19331.
   

   >> Share

   
   

   
   Biol Pharm Bull

5. OKADA N, Kimura H, Ozaki M, Tamura M, et al
   Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study.
   Biol Pharm Bull. 2026;49:335-340.
   

   >> Share

   
   

   
   BJU Int

6. AMER ML, Amer AR, Elnasharty SF, Homouda AA, et al
   Impact of perioperative nutrition on recovery after radical cystectomy: a randomised trial.
   BJU Int. 2026;137:536-546.
   

   >> Share

   
   

   
   BJUI Compass

7. FUKUHARA H, Shigehisa R, Yamamoto S, Fukata S, et al
   Effect of extending the oral administration period of 5-aminolevulinic acid on diagnostic accuracy and treatment outcomes for non-muscle-invasive bladder cancer.
   BJUI Compass. 2026;7:e70173.
   

   >> Share

   
   
8. CHEN KY, Jones MK, Ghosal S, Ignozzi GP, et al
   Predictors of adherence to surveillance cystoscopy for patients with non-muscle invasive bladder cancer.
   BJUI Compass. 2026;7:e70135.
   

   >> Share

   
   

   
   Cancer Lett

9. SUN Y, Tong H, Zhao G, Wu L, et al
   Nutrient Deprivation Promotes Bladder Cancer Metastasis through Beclin-1 Deacetylation-Mediated Autophagy Activation.
   Cancer Lett. 2026 Feb 16:218337. doi: 10.1016/j.canlet.2026.218337.
   

   >> Share

   
   

   
   Cancer Res

10. LUO W, Wang Y, Wang H, Ji YA, et al
    CCL5hi-CD4+ T cells Regulate Macrophage Polarization and Promote Immunotherapy Response in Bladder Cancer.
    Cancer Res. 2026 Feb 18. doi: 10.1158/0008-5472.CAN-25-2220.
    

    >> Share

    
    

    
    Cell

11. JONAS K, Moser T, Heitzer E
    Listening to the bladder field: Urine liquid biopsies reveal differential treatment responses in NMIBC.
    Cell. 2026;189:995-997.
    

    >> Share

    
    

    
    Cell Signal

12. GAO J, Pan Y, Cheng Q, Wang S, et al
    USP43 promotes lymphatic metastasis of bladder cancer by regulation of ZBTB7A.
    Cell Signal. 2026 Feb 18:112433. doi: 10.1016/j.cellsig.2026.112433.
    

    >> Share

    
    

    
    Eur Urol

13. SCILIPOTI P, Zaurito P, Longoni M, Colecchia M, et al
    Corrigendum to "Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guerin (BCG) in BCG-naive High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials" [Eur. Urol. (2025)].
    Eur Urol. 2026 Feb 17:S0302-2838(26)00063-1. doi: 10.1016/j.eururo.2026.
    

    >> Share

    
    

    
    Eur Urol Oncol

14. LONGONI M, Scilipoti P, De Angelis M, Zaurito P, et al
    Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.
    Eur Urol Oncol. 2026 Feb 19:S2588-9311(26)00042.
    

    >> Share

    
    

    
    FEMS Microbiol Lett

15. ACCETTO T, Strasek Smrdel K, Taskovska M, Starcic Erjavec M, et al
    Negative-control-anchored urinary microbiome profiling with absolute 16S quantification: a pilot study in newly diagnosed, treatment-naive bladder cancer and healthy individuals.
    FEMS Microbiol Lett. 2026 Feb 17:fnag020. doi: 10.1093.
    

    >> Share

    
    

    
    Front Cell Infect Microbiol

16. PAN S, Zhu H, Yin R, Lin J, et al
    Carcinogen metabolism and bladder cancer: role of gut microbiota in disease and prevention.
    Front Cell Infect Microbiol. 2026;15:1727550.
    

    >> Share

    
    

    
    Front Microbiol

17. LIU X, Chen Z, Lu Y, Wu Y, et al
    Fecal microbiota transplantation: a novel strategy and challenges in the adjuvant treatment of bladder Cancer.
    Front Microbiol. 2026;17:1756107.
    

    >> Share

    
    

    
    Front Oncol

18. SONG F, Su S, Zhang X, Cao Y, et al
    A nomogram based on the red cell distribution width to lymphocyte ratio as a prognostic tool for non-muscle-invasive bladder cancer: a retrospective study.
    Front Oncol. 2026;16:1728821.
    

    >> Share

    
    

    
    HPB (Oxford)

19. LAHIRI A, Chowdhury S, Goel S, Assif Iqbal S, et al
    Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study.
    HPB (Oxford). 2026 Feb 2:S1365-182X(26)00016-X. doi: 10.1016/j.hpb.2026.
    

    >> Share

    
    

    
    Int J Surg

20. XU C, Dong Y, Li J, Liao X, et al
    Integrating machine learning and mendelian randomization for identifying genetic biomarkers in bladder cancer: implications for early diagnosis and targeted therapies.
    Int J Surg. 2025 Dec 3. doi: 10.1097/JS9.0000000000003833.
    

    >> Share

    
    

    
    Int J Urol

21. KUSANO S, Tobu S, Yukimoto M, Yamaguchi Y, et al
    Palliative Intra-Arterial Chemotherapy Without Radiotherapy for Elderly Patients With Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Comparison With Radical Cystectomy and Best Supportive Care.
    Int J Urol. 2026;33:e70386.
    

    >> Share

    
    

    
    iScience

22. ZHANG J, Wang J, Hu X, Jia W, et al
    Biomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth.
    iScience. 2026;29:114786.
    

    >> Share

    
    
23. HUANG X, Meng Y, Song J, Zhu Y, et al
    KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.
    iScience. 2026;29:114734.
    

    >> Share

    
    
24. HU J, Zhu Y, Wang G, Dai H, et al
    SNW1 promotes lymphatic metastasis in bladder cancer by modulating SRPK1 splicing.
    iScience. 2026;29:114811.
    

    >> Share

    
    

    
    J Clin Pathol

25. WEBER TD, Gershman B, Wang L, Rosen S, et al
    Rapid evaluation of muscularis propria in transurethral resection of bladder tumour specimens using non-linear microscopy (NLM).
    J Clin Pathol. 2026;79:186-191.
    

    >> Share

    
    

    
    J Pediatr Urol

26. WEIR S, Murgas KA, Froehlich M, Nash M, et al
    Urothelial cell carcinoma of the bladder in pediatric patients: A comparison with adults from the National Cancer Database.
    J Pediatr Urol. 2026;22:105677.
    

    >> Share

    
    

    
    J Transl Med

27. ZHANG H, Han S, Su Z, Zheng Z, et al
    Single-cell transcriptomic analysis and machine learning identify ATAD3A as a key gene that stabilizes mitochondrial-endoplasmic reticulum membranes, promoting bladder cancer progression.
    J Transl Med. 2026 Feb 20. doi: 10.1186/s12967-026-07857.
    

    >> Share

    
    

    
    J Urol

28. RITCH C, Anderson CB
    Cystoscopic Fulguration for Patients with Recurrent Low-Grade Bladder Cancer.
    J Urol. 2026 Feb 18:101097JU0000000000004974. doi: 10.1097/JU.0000000000004974.
    

    >> Share

    
    
29. ZHANG S, Li T, Li D, Yin Y, et al
    Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial.
    J Urol. 2026 Feb 17:101097JU0000000000004993. doi: 10.1097/JU.0000000000004993.
    

    >> Share

    
    

    
    JMIR Perioper Med

30. CAUSIO FA, De Vita V, Nappi A, Sawaya M, et al
    Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center Study.
    JMIR Perioper Med. 2026;9:e86666.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

31. KATO M, Matsue T, Yamamoto S, Yukimatsu N, et al
    Clinical impact of carboplatin-based neoadjuvant chemotherapy: lack of benefit and surgical delay in muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2026 Feb 19:hyag027. doi: 10.1093.
    

    >> Share

    
    

    
    Life Sci Alliance

32. HINLEY J, Baker SC, Mason AS, Kyriazis G, et al
    Connexin 32 constrains a mesenchymal-like switch in differentiated urothelium and luminal cancers.
    Life Sci Alliance. 2026;9:e202503427.
    

    >> Share

    
    

    
    Minerva Urol Nephrol

33. LAMBERTINI L, Saladino M, DI Maida F, Grosso AA, et al
    Oncologic outcomes after robot assisted radical cystectomy in patients with clinically positive lymph nodes (cN1): a tertiary referral center experience.
    Minerva Urol Nephrol. 2026;78:118-126.
    

    >> Share

    
    
34. CRESTANI B, Tamborrino V, Bertolo R, Antonelli A, et al
    Balancing maternal and fetal safety in non-muscle-invasive bladder cancer: report of our experience.
    Minerva Urol Nephrol. 2026;78:155-157.
    

    >> Share

    
    

    
    N Engl J Med

35. VULSTEKE C, Adra N, Danchaivijitr P, Sabadash M, et al
    Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
    N Engl J Med. 2026 Feb 18. doi: 10.1056/NEJMoa2511674.
    

    >> Share

    
    

    
    Nanoscale

36. ZHANG P, Xiong W, Wang K, Zhao X, et al
    Copper-based architectures for bladder cancer therapy: mechanistic insights, progress and prospects.
    Nanoscale. 2026 Feb 19. doi: 10.1039/d5nr04072.
    

    >> Share

    
    

    
    Photodiagnosis Photodyn Ther

37. LI H, Long G, Hu L, Wang Q, et al
    Intravesical hematoporphyrin photodynamic therapy combined with pirarubicin for intermediate and high-risk non-muscle-invasive bladder cancer: a multicenter, prospective single-arm cohort.
    Photodiagnosis Photodyn Ther. 2026 Feb 14:105396.
    

    >> Share

    
    

    
    PLoS One

38. SHEN J, Zhao Z, Li Z, Wang R, et al
    Bladder cancer-induced CVD mortality: Role of CAPG protein.
    PLoS One. 2026;21:e0338101.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

39. GALSKY MD, Izadmehr S, Yu M, Curtis SD, et al
    Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2533449123.
    

    >> Share

    
    

    
    Urol Ann

40. INDRASWARI MT, Rahman F, Hamid ARAH, Mochtar CA, et al
    Psychological distress among bladder cancer patients: A systematic review.
    Urol Ann. 2026;18:10-17.
    

    >> Share

    
    

    
    Urol Oncol

41. QU M, Wei J, Mo J, Chen J, et al
    Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy.
    Urol Oncol. 2026;44:110970.
    

    >> Share

    
    
42. DAS M, Rath S, Gorepatti R, Dash R, et al
    Microbiome-linked transcriptomic signatures in NMIBC: Toward personalized uro-oncology.
    Urol Oncol. 2026;44:110977.
    

    >> Share

    
    

    
    World J Mens Health

43. KWON J, Jeon J, Lee HS, Jeon S, et al
    Effects of Radiation Therapy on the Incidence of Bladder Cancer and Rectal Cancer in Patients with Prostate Cancer: A Nationwide Nested Case-Control Study in Korean Population.
    World J Mens Health. 2026 Jan 15. doi: 10.5534/wjmh.250298.
    

    >> Share

    
    

    
    World J Urol

44. KOHLER J, Buck L, Hugelmann K, Incesu RB, et al
    Chronological and biological age stratify survival after robot-assisted radical cystectomy for bladder cancer: a pragmatic age-ECOG risk score.
    World J Urol. 2026;44:178.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share